Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown    symbols : PIRS    save search
Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published: 2021-04-26 (Crawled : 13:15) - biospace.com/
PIRS | $0.1455 -6.25% -6.67% 1.9M twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 6.8% C: 6.14%
license gpt-3
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.